A First in Human Study for the Versa Device for Tricuspid Regurgitation
NCT: NCT06368401 · ACTIVE_NOT_RECRUITING
Brief Summary
This study is prospective, non-randomized, single-arm,first in human study to evaluate the safety and feasibility of the Versa Vascular System for intervention in adults with severe tricuspid regurgitation who are not surgical candidates.
Frequently Asked Questions
What is A First in Human Study for the Versa Device for Tricuspid Regurgitation?
A First in Human Study for the Versa Device for Tricuspid Regurgitation is a clinical trial registered under NCT06368401. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06368401?
The current status of NCT06368401 (A First in Human Study for the Versa Device for Tricuspid Regurgitation) is: ACTIVE_NOT_RECRUITING.
When did A First in Human Study for the Versa Device for Tricuspid Regurgitation start?
A First in Human Study for the Versa Device for Tricuspid Regurgitation started on 2024-08-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.